3,900 per cent returns in this multibagger stock; Board announces stock split!

The stock gave multibagger returns of 440 per cent in just 3 years and a whopping 3,900 per cent in a decade.

Themis Medicare Ltd announced that the Board of Directors of the company approved a sub-division/ stock split of every 1 fully paid-up equity share having a face value of Rs 10 each in the authorised share capital of the company, into 10 fully paid-up equity shares having face value of Rs 1 each as of record date. The company fixed the record date as Tuesday, October 10, 2023.

Themis Medicare is principally engaged in the activities pertaining to the manufacturing of pharmaceutical products, especially in Formulation and API activity.

Talking about the financials, Themis Medicare has a market cap of over Rs 1,500 crore and has delivered good profit growth of 36.9 per cent CAGR over the last 5 years. The company reported positive numbers in its Quarterly Results and annual results. The net sales increased by 3.2 per cent to Rs 97 crore and net profit increased by 5.9 per cent to Rs 18 crore in Q1FY24 compared to Q1FY23.

On Friday, shares of Themis Medicare Ltd plunged 0.29 per cent to Rs 1,695.7 per share from its previous closing of Rs 1,700.7 per share. The stock traded at an intraday high of Rs 1,719.75 and an intraday low of Rs 1,687.9.

The shares of the company have a PE of 27.3x, an ROE of 17.3 per cent and an ROCE of 19.7 per cent. The stock gave multibagger returns of 440 per cent in just 3 years and a whopping 3,900 per cent in a decade. Investors should keep an eye on this Small-Cap stock.

Disclaimer: The article is for informational purposes only and not investment advice.